HK Stock Market Move | STAR SPORTS MED (01609) once surged over 36% intraday, recently obtained EU MDR certification and product registration approvals in multiple overseas markets.

STAR SPORTS MED (01609) once surged over 36% intraday, as of press time, up 12.66%, at HK$113, with a turnover of HK$71.1653 million. On the news front, STAR SPORTS MED announced that recently, the Company received the EU Medical Device Regulation (CE MDR) certification certificate, becoming the first sports medicine manufacturer in China to obtain CE MDR certification for its entire product line. The aforementioned certificate covers products including all-suture anchors, all-suture loop plates, continuous suture multi-needle meniscus devices, metal suture anchors, polyetheretherketone suture anchors, carbon fiber composite suture anchors, and other 15 categories of products. The above products include implants, active devices and consumables, and endoscopic surgical instruments, and can provide comprehensive clinical solutions for six major joints: shoulder, knee, hip, elbow, wrist, and foot and ankle. At the same time, the Company's registration applications submitted in the United Kingdom, Australia, Brazil, Singapore, Malaysia, Thailand, and other countries for plasma surgical equipment and electrodes, all-suture anchors, suture products, and other products have been approved successively, and registration certificates issued by the local competent authorities have been obtained. The obtaining of the above certification certificates and registration certificates marks that more of the Company's products comply with the regulatory requirements of the EU and the above countries, which is conducive to the Company's further expansion of its overseas business layout in the EU, Latin America, and Southeast Asia, and further enhances the Company's competitiveness and product layout in the international market.